RecruitingNCT07206472

A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

A Multi-national, Non-interventional Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

Sponsor

Daiichi Sankyo

Enrollment

2,120 participants

Start Date

Mar 3, 2026

Study Type

OBSERVATIONAL

Conditions

mixed dyslipidemia Primary Hypercholesterolaemia

Summary

There is limited efficacy and safety data of bempedoic acid or its fixed dose combination (FDC) with ezetimibe in Asian and Latin American patients. This non-interventional study (NIS) will be conducted to characterize the risks and benefits of bempedoic acid or FDC with ezetimibe in a real-world clinical setting in adult patients with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Combination of bempedoic acid and ezetimibe for people with primary hypercholesterolaemia and mixed dyslipidemia. The study is currently recruiting participants at 23 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCombination of bempedoic acid and ezetimibe

No drug was administered in this observational study.

Locations(23)

Hospital Mater Dei Contorno

Belo Horizonte, Brazil

Hospital Felício Rocho

Belo Horizonte, Brazil

Hospital Vera Cruz

Belo Horizonte, Brazil

Clinica Procardio Ltda.

Blumenau, Brazil

Universidade de Caxias do Sul (UCS)

Caixias Do Sul, Brazil

Hospital e Maternidade Angelina Caron

Campina Grande do Sul, Brazil

Pontificia Universidade Catolica do Parana-(PUCPR)

Curitiba, Brazil

CMEP Centro Multidisciplinar de Ensino Especializado e Pesquisa LTDA

Joinville, Brazil

Galileo Medical Research Ltda.

Juiz de Fora, Brazil

Hospital Parana - Parana Medical Research Center

Maringá, Brazil

Hospital Maternidade e Pronto Socorro Santa Lucia

Pocos de Calda, Brazil

Hospital Moinhos de Vento (HMV)

Porto Alegre, Brazil

Fundacao Bahiana de Infectologia

Salvador, Brazil

Hospital da Mater Dei Salvador

Salvador, Brazil

Hospital E Maternidade Dr. Cristavao da Gama (HMCG)

Santo André, Brazil

BP - A Beneficencia Portuguesa de Sao Paulo

São Paulo, Brazil

Hospital Alemao Oswaldo Cruz (HAOC)

São Paulo, Brazil

Instituto Conceive Ltda

São Paulo, Brazil

Cardial Servicos Medicos Especializados

São Paulo, Brazil

Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - InCor HCFMUSP

São Paulo, Brazil

Universidade de Sao Paulo (USP) - Hospital das Clinicas da Faculdade de Medicina

São Paulo, Brazil

Instituto de Molestias Cardiovasculares Tatui

Tatuí, Brazil

The University of Hong Kong, Queen Mary Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07206472

Related Trials

Phase 2 Clinical Study of MWX203 Injection Alone or in Combination With Inclisiran Sodium Injection in Patients With Mixed Dyslipidemia

NCT07803822

A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT06686615163 locations

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

NCT076149581 location

A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

NCT063149191 location

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

NCT069327051 location